Tag: Rymti
Lupin launches Rymti biosimilar for chronic inflammatory diseases in Canada
The approval of Rymti® by Health Canada underlines the scientific success of Lupin’s biosimilar programs
Lupin’s Rymti gets approval from Canadian regulator
Rymti is Lupin’s biosimilar etanercept approved for all indications of the reference product, Enbrel